Kathleen M Whalen Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week ago
Kathleen M Whalen has an estimated net worth of at least $10.1 million*, as of Dec. 18, 2024. They own 9,454 shares of HCA stock. They have sold 23,642 shares of HCA stock since 2021, for an estimated $7.2 million.
Kathleen M Whalen $HCA SEC Form 4 Insider Trading
Kathleen M Whalen has filed a total of 10 insider trades in $HCA since 2021. Their most recent trade was a sale of 1,474 shares, made on Nov 14, 2024. Their largest trade was a sale of 4,262 shares, made on Feb 09, 2024. We estimate that they now own 9,454 shares of $HCA, worth an estimated $2.9 million.
Insider Trading at $HCA
There have been a total of 96 insider trades reported at $HCA since 2021, with 91,695 shares purchased and 488,240 shares sold. The most active insider traders in $HCA stock have been Kathryn A. Torres, Kathleen M Whalen, and Michael S. Cuffe. The most recent trade was a sale of 1,474 shares reported by Kathleen M Whalen (SVP & Chief Ethics Officer), made on Nov 14, 2024.
History of Insider Stock Trades by Kathleen M Whalen
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
HCA | Sale | 1,474 | Nov 14, 2024 | Nov. 18, 2024, 6:50 p.m. |
HCA | Sale | 2,987 | Jul 31, 2024 | July 31, 2024, 5:44 p.m. |
HCA | Sale | 1,864 | Jul 29, 2024 | July 31, 2024, 5:44 p.m. |
HCA | Sale | 3,204 | May 16, 2024 | May 20, 2024, 5:23 p.m. |
HCA | Sale | 4,262 | Feb 09, 2024 | Feb. 13, 2024, 8:03 p.m. |
HCA | Sale | 2,916 | Aug 03, 2023 | Aug. 7, 2023, 4:39 p.m. |
HCA | Sale | 1,734 | Feb 17, 2023 | Feb. 22, 2023, 9:10 p.m. |
HCA | Sale | 500 | May 03, 2022 | May 5, 2022, 5:05 p.m. |
HCA | Sale | 3,815 | Nov 04, 2021 | Nov. 3, 2021, 8 p.m. |
HCA | Sale | 886 | Jul 22, 2021 | July 25, 2021, 8 p.m. |
$HCA Executives and Stock Owners with Insider Trades
-
Kathryn A. Torres, SVP-Payer Contracting & Align.
-
Kathleen M Whalen, SVP & Chief Ethics Officer
-
Michael S. Cuffe, EVP and Chief Clinical Officer
-
Charles J Hall, Group President
-
P. Martin Paslick, SVP and CIO
-
Jane D. Englebright, SVP and Chief Nursing Officer
-
Jonathan B Perlin, Pres-Clinical Operations & CMO
-
Bill B Rutherford, CFO and EVP
-
Christopher F. Wyatt, SVP & Controller
-
Samuel N Hazen, CEO
-
Phillip G Billington, SVP-Internal Audit Services
-
Joseph A Iii Sowell, SVP; Chief Development Officer
-
A Bruce Jr Moore, Group President - Service Line
-
Jon M Foster, Group President
-
Erol R Akdamar, Group President
-
Deborah M Reiner, SVP - Mktg. & Communications
-
Chad J Wasserman, SVP and CIO
-
Jennifer Berres, SVP & Chief Human Res. Officer
-
Jeffrey E. Cohen, SVP-Government Relations
-
Timothy M Mcmanus, Group President
-
Jon M Foster, EVP and COO
-
Michael R Mcalevey, SVP & Chief Legal Officer
-
Michael S. Cuffe, President-Physician Services
-
Sammie S Mosier, SVP & Chief Nurse Executive
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.